Loading
NASDAQHealthcareMedical - Diagnostics & Research
Latest quote
$1.11
+$0.01 · +0.91%
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
Regular session
$1.11
+$0.01 · +0.91%
Regular session · ET · Market data may be delayed.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
Day range
Current $1.11
52-week range
Current $1.11
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
16
Overpriced
Sentiment
52
Mixed
Risk
74
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
Day range
Current $1.11
52-week range
Current $1.11
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.93M USD | 9.29M USD | 9.93M USD | 10.4M USD | 11.14M USD |
| Cost of goods sold | 1.9M USD | 5.3M USD | 4.82M USD | 4.76M USD | 5.25M USD |
| Gross profit | 24.11K USD | 3.99M USD | 5.11M USD | 5.65M USD | 5.89M USD |
| Research and development | 2.16M USD | 3.53M USD | 3.57M USD | 2.66M USD | 1.84M USD |
| Selling, general, and administrative | 6.6M USD | 12.65M USD | 11.68M USD | 12.37M USD | 9.4M USD |
| Operating expenses | 9M USD | 16.72M USD | 16.28M USD | 15.83M USD | 11.81M USD |
| Interest income | 3.75K USD | 44.13K USD | 339.75K USD | 169.35K USD | 11.4K USD |
| Interest expense | 1.95K USD | 220.07K USD | 230.79K USD | 238.96K USD | 2.1M USD |
| Depreciation and amortization | 1.73M USD | 2.29M USD | 2.12M USD | 1.21M USD | 1M USD |
| Operating income | −8.98M USD | −12.73M USD | −11.17M USD | −10.19M USD | −5.93M USD |
| Net income | −10.49M USD | −12.5M USD | −11.1M USD | −10.25M USD | −8.96M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Apr 28, 2026 | 1:40 | — | — |
Stock split | Sep 16, 2024 | 1:20 | — | — |
Effective Apr 28, 2026
1:40
Effective Sep 16, 2024
1:20
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
